Citizens Reiterates Market Outperform on BeOne Medicines, Maintains $396 Price Target
Citizens analyst Reni J. Benjamin reiterates BeOne Medicines (NASDAQ: ONC ) with a Market Outperform and maintains $396 price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.